← All trials
NCT01116986
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- May 1, 2014
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 637
- Arms / groups
- 32 / —
- Source
- AACT · pre-existing
Sponsors
- University of WisconsinLead sponsor
- University of WisconsinOverall official - principal investigator
- University of WisconsinStudy director
- Dean Health SystemCollaborator
- National Cancer Institute (NCI)Collaborator
- Mercy Health System, WisconsinCollaborator
- University of WisconsinCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.